Malaria Company
Artecef® 50 and 150
A-CQ 100®, Chloroquine 100 mg tablets
A-PQ 30®, Primaquine 30 mg
Malacef® 60 (Artesunate 60 mg pfi)
A-QS 200®, Quinine Sulphate-dihydrate 200 mg
Orderform
Questions / Adverse Events / Complaints
News
Contact us
To ACE group of companies
To ACE Pharmaceuticals BV

The Malaria Company 

Artecef® 50, im-injection

NL RVG 24880 and SA 33/20.2.6./0305

Artecef® 150, im-injection NL RVG 24881 and SA 33/20.2.6./0304
A-CQ 100® Chloroquine 100 mg NL RVG 106659
A-PQ 30®, Primaquine 30 mg Reimbursed

A-QS 200® Quinine Sulphate-dihydrate 200 mg

 NL RVG 52455
Malacef® 60, pfi Orphan Drug Designation EU/3/07/430
ATU Nominative



Artecef® 50 and 150 on the procurementlist of UN-agencies Quality and Safety Group of WHO, March 2006; LTA with UNICEF per November 2007, prolonged per November 2009.

ARTECEF BV is a subsidiary of ACE group of companies.  

EnglishNederlands
Malacef® 60: the name for ARTESUNATE 60 mg, pfi
19 March 2009
ARTESUNATE 60 mg, pfi will get the registered tradename Malacef® 60.
© 2012, ARTECEF BV. All rights reserved.